Abstract
2-Fluorophenyl isocyanate reacted with adamantan-1(2)-amines and their homologs in DMF to give 31–92% of the corresponding N,N′-disubstituted ureas that are target-oriented human soluble epoxide hydrolase (sEH) inhibitors. Introduction of a fluorine atom increases the sEH inhibitory activity by a factor of 4.5.
Similar content being viewed by others
References
Spiecker, M. and Liao, J.K., Arch. Biochem. Biophys., 2005, vol. 433, p.413.
Decker, M., Arand, M., and Cronin, A., Arch. Toxicol., 2009, vol. 83, p.297.
Schmelzer, K.R., Inceoglu, B., Kubala, L., Kim, I.H., Jinks, S.L., Eiserich, J.P., and Hammock, B.D., Proc. Natl. Acad. Sci. U. S. A., 2006, vol. 103, p. 13646.
Wagner, K., Inceoglu, B., Gill, S.S., and Hammock, B.D., J. Agric. Food Chem., 2011, vol. 59, p. 2816.
Guedes, A.G., Morisseau, C., Sole, A., Soares, J.H., Ulu, A., Dong, H., and Hammock, B.D., Vet. Anaesth. Analg., 2013, vol. 40, p.440.
Hung, Y.W., Hung, S.W., Wu, Y.C., Wong, L.K., Lai, M.T., Lee, T.S., Shih, Y.H., and Lin, Y.Y., Brain Behav. Immun., 2015, vol. 43, p.118.
Imig, J.D., Expert Opin. Drug Metab. Toxicol., 2008, vol. 4, p.165.
Hwang, S.H., Wecksler, A.T., Zhang, G., Morisseau, C., Nguyen, L.V., Fu, S.H., and Hammock, B.D., Bioorg. Med. Chem. Lett., 2013, vol. 23, p. 3732.
Burmistrov, V., Morisseau, C., Harris, T.R., Butov, G., and Hammock, B.D., Bioorg. Chem., 2018, vol. 76, p.510.
Kodani, S.D. and Hammock, B.D., Drug Metab. Dispos., 2015, vol. 43, p.788.
Wagner, K., Inceoglu, B., Dong, H., Yang, J., Hwang, S.H., Jones, P., Morisseau, C., and Hammock, B.D., Eur. J. Pharmacol., 2013, vol. 700, p.93.
Grzegorzewicz, A.E., Pham, H., Gundi, V.A.K.B., Scherman, M.S., North, E.J., Hess, T., Jones, V., Gruppo, V., Born, S.E.M., Korduláková, J., Chavadi, S.S., Morisseau, C., Lenaerts, A.J., Lee, R.E., McNeil, M.R., and Jackson, M., Nat. Chem. Biol., 2012, vol. 8, p.334.
Scherman, M.S., North, E.J., Jones, V., Hess, T.N., Grzegorzewicz, A.E., Kasagami, T., Kim, I.-H., Merzlikin, O., Lenaerts, A.J., Lee, R.E., Jackson, M., Morisseau, C., and McNeil, M.R., Bioorg. Med. Chem., 2012, vol. 20, p. 3255.
Burmistrov, V.V., Butov, G.M., and D’yachenko, V.S., Russ. J. Org. Chem., 2016, vol. 52, p.582.
Burmistrov, V.V., Pitushkin, D.A., Vasipov, V.V., and Butov, G.M., Russ. J. Org. Chem., 2017, vol. 53, p. 1176.
Butov, G.M., Burmistrov, V.V., and Danilov, D.V., Russ. Chem. Bull., Int. Ed., 2017, vol. 66, no. 10, p. 1876.
Butov, G.M., Burmistrov, V.V., and D’yachenko, V.S., Russ. J. Org. Chem., 2017, vol. 53, p.977.
Kasagami, T., Kim, I.-H., Tsai, H.-J., Nishi, K., Hammock, B.D., and Morisseau, C., Bioorg. Med. Chem. Lett., 2009, vol. 19, p. 1784.
Huang, X., Zhuang, T., Kates, P.A., Gao, H., Chen, X., and Groves, J.T., J. Am. Chem. Soc., 2017, vol. 139, p. 15407.
Novakov, I.A., Kulev, I.A., Radchenko, S.S., Birzniens, K.A., Boreiko, E.I., Vladyko, G.V., and Korobchenko, L.V., Pharm. Chem. J., 1987, vol. 21, p.454.
Aldrich, P.E., Hermann, E.C., Meier, W.E., Paulshock, M., Prichard, W.W., Synder, J.A., and Watts, J.C., J. Med. Chem., 1971, vol. 14, p.535.
Averin, A.D., Ranyuk, E.R., Golub, S.L., Buryak, A.K., Savelyev, E.N., Orlinson, B.S., Novakov, I.A., and Beletskaya, I.P., Synthesis, 2007, no. 14, p. 2215.
Stetter, H., Weber, J., and Wulff, C., Chem. Ber., 1964, vol. 97, p. 3488.
Henkel, J.G., Hane, J.T., and Gianutsos, G., J. Med. Chem., 1982, vol. 25, p.51.
Smith, G.W. and Williams, H.D., J. Org. Chem., 1961, vol. 26, p. 2207.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.V. Burmistrov, G.M. Butov, 2018, published in Zhurnal Organicheskoi Khimii, 2018, Vol. 54, No. 9, pp. 1296–1301.
Rights and permissions
About this article
Cite this article
Burmistrov, V.V., Butov, G.M. Synthesis and Properties of N-[R-Adamantan-1(2)-yl]-N′-(2-fluorophenyl)ureas—Target-Oriented Soluble Epoxide Hydrolase Inhibitors. Russ J Org Chem 54, 1307–1312 (2018). https://doi.org/10.1134/S1070428018090063
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070428018090063